NutraLife BioSciences, Inc.
NLBS · OTC
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Market Cap | $13 | $14 | $8 | $17 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $3 | $3 | $2 | $0 |
| Enterprise Value | $16 | $17 | $10 | $17 |
| Revenue | $1 | $1 | $2 | $4 |
| % Growth | -50.1% | -41.1% | -42.5% | – |
| Gross Profit | $0 | $1 | $1 | $2 |
| % Margin | 13.3% | 40.6% | 28% | 40.4% |
| EBITDA | -$4 | -$2 | -$4 | -$2 |
| % Margin | -582.8% | -125.7% | -176.6% | -50.5% |
| Net Income | -$6 | -$3 | -$4 | -$2 |
| % Margin | -930% | -230.1% | -187.8% | -55.9% |
| EPS Diluted | -0.04 | -0.02 | -0.036 | -0.024 |
| % Growth | -102% | 45% | -51.3% | – |
| Operating Cash Flow | -$0 | -$1 | -$3 | -$0 |
| Capital Expenditures | $0 | $0 | -$2 | -$1 |
| Free Cash Flow | -$0 | -$1 | -$5 | -$1 |